相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment -Based Drug Design
Katherine L. Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Toll-like receptors: promising therapeutic targets for inflammatory diseases
Asma Achek et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Toll-like receptors and chronic inflammation in rheumatic diseases: new developments
Leo A. B. Joosten et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4
William T. McElroy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4
Zhulun Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system
Matthew C. Walsh et al.
IMMUNOLOGICAL REVIEWS (2015)
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
Priscilla N. Kelly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain
Pragnesh Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation
William T. McElroy et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4
Jongwon Lim et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Cholesterol, inflammation and innate immunity
Alan R. Tall et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4
L. Nathan Tumey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Interleukin 1/Toll-like Receptor-induced Autophosphorylation Activates Interleukin 1 Receptor-associated Kinase 4 and Controls Cytokine Induction in a Cell Type-specific Manner
Leah Cushing et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Quantitative Proteomic Analysis of the Influenza A Virus Nonstructural Proteins NS1 and NS2 during Natural Cell Infection Identifies PACT as an NS1 Target Protein and Antiviral Host Factor
Kazuki Tawaratsumida et al.
JOURNAL OF VIROLOGY (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor
Gemma Vilahur et al.
FRONTIERS IN PHYSIOLOGY (2014)
Hematopoietic progenitor cell lines with myeloid and lymphoid potential
Vanessa Redecke et al.
NATURE METHODS (2013)
Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli
Greg A. Snyder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Experimental and natural infections in MyD88-and IRAK-4-deficient mice and humans
Horst von Bernuth et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
TLR7 and TLR9 in SLE: when sensing self goes wrong
T. Celhar et al.
IMMUNOLOGIC RESEARCH (2012)
A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease
Jingran Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling
Su-Chang Lin et al.
NATURE (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Update on the role of Toll-like receptors during bacterial infections and sepsis
Sylvia Knapp
WIENER MEDIZINISCHE WOCHENSCHRIFT (2010)
Toll-like receptors and innate immunity
Himanshu Kumar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Gene-specific control of the TLR-induced inflammatory response
Simmie L. Foster et al.
CLINICAL IMMUNOLOGY (2009)
IRAK-4 inhibitors.: Part III:: A series of imidazo[1,2-a] pyridines
George M. Buckley et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
IRAK-4 inhibitors.: Part II:: A structure-based assessment of imidazo[1,2-a]pyridine binding
George M. Buckley et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Identification of a potent, selective, and orally active leukotriene A4 hydrolase inhibitor with anti-inflammatory activity
Cheryl A. Grice et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Origin and physiological roles of inflammation
Ruslan Medzhitov
NATURE (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
The role of interleukin-1 and the inflammasome in gout - Implications for therapy
Richard M. Pope et al.
ARTHRITIS AND RHEUMATISM (2007)
Pivotal Advance:: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound
Maria Loiarro et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor- mediated immune responses but not in TCR signaling
Tatsukata Kawagoe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity
Tae Whan Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression
Magdalena Koziczak-Holbro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Dectin-1 is required for beta-glucan recognition and control of fungal infection
Philip R. Taylor et al.
NATURE IMMUNOLOGY (2007)
Crystal structures of IRAK-4 kinase in complex with inhibitors: A serine/threonine kinase with tyrosine as a gatekeeper
Zhulun Wang et al.
STRUCTURE (2006)
MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals
Chun-Jen Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4
JP Powers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6
H Häcker et al.
NATURE (2006)
Interactive sites in the MyD88 toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1β signaling pathway
CS Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cutting edge:: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF)-dependent pathway in TLR signaling
J Gohda et al.
JOURNAL OF IMMUNOLOGY (2004)
TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-β
H Oshiumi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF
KA Fitzgerald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway
M Yamamoto et al.
SCIENCE (2003)
TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction
H Oshiumi et al.
NATURE IMMUNOLOGY (2003)
TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway
M Yamamoto et al.
NATURE IMMUNOLOGY (2003)
The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors
T Horng et al.
NATURE (2002)
Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4
M Yamamoto et al.
NATURE (2002)
NF-κB as a therapeutic target in multiple myeloma
T Hideshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4
N Suzuki et al.
NATURE (2002)
IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase
SY Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Antagonists selective for estrogen receptor alpha
J Sun et al.
ENDOCRINOLOGY (2002)
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction
KA Fitzgerald et al.
NATURE (2001)
TIRAP: an adapter molecule in the Toll signaling pathway
T Horng et al.
NATURE IMMUNOLOGY (2001)
Estrogen pyrazoles: Defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptor
SR Stauffer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Triarylpyrazoles with basic side chains: Development of pyrazole-based estrogen receptor antagonists
SR Stauffer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Pyrazole ligands:: Structure-affinity/activity relationships and estrogen receptor-α-selective agonists
SR Stauffer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Regioselective synthesis of 1,3,5-triaryl-4-alkylpyrazoles: Novel ligands for the estrogen receptor
YR Huang et al.
ORGANIC LETTERS (2000)
Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6
H Häcker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)